AGENDA

2:00-2:10  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

Review of EPA’s TSCA New Chemicals Collaborative Research Program Meeting – April 20-21, 2022

On Wednesday, April 20, 2022 I had the opportunity to testify on behalf of the NanoBCA at the EPA’s TSCA New Chemicals Collaborative Research Program Meeting. I would like to share my testimony with our nanotechnology community.

CLICK HERE TO VIEW MY TESTIMONY

2:10-2:30  EHS Update 
Lynn L. Bergeson
Managing Director, Bergeson & Campbell, P.C.
NanoBCA EHS Chair
lbergeson@lawbc.com

James V. Aidala
Senior Government Affairs Consultant, Bergeson & Campbell, P.C.
jaidala@lawbc.com

FDA Publishes Final Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials

Senate Committee Hearing on Proposed FY 2023 EPA Budget Includes Discussion of TSCA and FIFRA Issues

Meeting Recordings and Transcript Available for TSCA SACC Peer Review of Screening Level Approach for Assessing Ambient Air and Water Exposures to Fenceline Communities

2:30-2:45 Review of EPA’s TSCA New Chemicals Collaborative Research Program Meeting – April 20-21, 2022
2021 NanoBCA Lifetime Achievement Award Recipient
Sam Brauer, PhD
Founder & Principal, Nanotech Plus
sbrauer@nano-biz.com

CLICK HERE TO VIEW SAM BRAUER’S TESTIMONY

2:45-3:00 Q&A

3:00 Conclusion